349 related articles for article (PubMed ID: 36467615)
1. Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences.
Banerjee S; Baidya SK; Adhikari N; Ghosh B; Jha T
J Mol Struct; 2023 Mar; 1275():134642. PubMed ID: 36467615
[TBL] [Abstract][Full Text] [Related]
2. The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions.
Gomaa AA; Abdel-Wadood YA
Phytomed Plus; 2021 Aug; 1(3):100043. PubMed ID: 35399823
[TBL] [Abstract][Full Text] [Related]
3. In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis.
Gajjar ND; Dhameliya TM; Shah GB
J Mol Struct; 2021 Sep; 1239():130488. PubMed ID: 33903778
[TBL] [Abstract][Full Text] [Related]
4. Identification of Leading Compounds from
Islam MN; Pramanik MEA; Hossain MA; Rahman MH; Hossen MS; Islam MA; Miah MMZ; Ahmed I; Hossain AM; Haque MJ; Islam AM; Ali MN; Jahan RA; Haque ME; Rahman MM; Hasan MS; Rahman MM; Kabir MM; Basak PM; Sarkar MAM; Islam MS; Rahman MR; Prodhan AA; Mosaddik A; Haque H; Fahmin F; Das HS; Islam MM; Emtia C; Gofur MR; Liang A; Akbar SMF
Euroasian J Hepatogastroenterol; 2023; 13(2):89-107. PubMed ID: 38222948
[TBL] [Abstract][Full Text] [Related]
5. Bioactive natural compounds against human coronaviruses: a review and perspective.
Xian Y; Zhang J; Bian Z; Zhou H; Zhang Z; Lin Z; Xu H
Acta Pharm Sin B; 2020 Jul; 10(7):1163-1174. PubMed ID: 32834947
[TBL] [Abstract][Full Text] [Related]
6. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic.
Liang C; Hui N; Liu Y; Qiao G; Li J; Tian L; Ju X; Jia M; Liu H; Cao W; Yu P; Li H; Ren X
Phytomed Plus; 2021 May; 1(2):100027. PubMed ID: 35399819
[TBL] [Abstract][Full Text] [Related]
7. Nature's therapy for COVID-19: Targeting the vital non-structural proteins (NSP) from SARS-CoV-2 with phytochemicals from Indian medicinal plants.
Parida PK; Paul D; Chakravorty D
Phytomed Plus; 2021 Feb; 1(1):100002. PubMed ID: 35403083
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
9. Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19.
Patil R; Chikhale R; Khanal P; Gurav N; Ayyanar M; Sinha S; Prasad S; Dey YN; Wanjari M; Gurav SS
Inform Med Unlocked; 2021; 22():100504. PubMed ID: 33363251
[TBL] [Abstract][Full Text] [Related]
10. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
[TBL] [Abstract][Full Text] [Related]
11. Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery.
Wang Z; Yang L; Zhao XE
Comput Struct Biotechnol J; 2021; 19():4684-4701. PubMed ID: 34426762
[TBL] [Abstract][Full Text] [Related]
12. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants.
Yin J; Li C; Ye C; Ruan Z; Liang Y; Li Y; Wu J; Luo Z
Comput Struct Biotechnol J; 2022; 20():824-837. PubMed ID: 35126885
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2.
He MF; Liang JH; Shen YN; Zhang JW; Liu Y; Yang KY; Liu LC; Wang J; Xie Q; Hu C; Song X; Wang Y
Life (Basel); 2022 Oct; 12(11):. PubMed ID: 36362861
[TBL] [Abstract][Full Text] [Related]
14. Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity.
Haddad M; Gaudreault R; Sasseville G; Nguyen PT; Wiebe H; Van De Ven T; Bourgault S; Mousseau N; Ramassamy C
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269785
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking, molecular dynamics simulation and MM-GBSA studies of the activity of glycyrrhizin relevant substructures on SARS-CoV-2 RNA-dependent-RNA polymerase.
Zamzami MA
J Biomol Struct Dyn; 2023 Mar; 41(5):1846-1858. PubMed ID: 35037842
[TBL] [Abstract][Full Text] [Related]
16. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
Khare P; Sahu U; Pandey SC; Samant M
Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
[TBL] [Abstract][Full Text] [Related]
17. Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing.
Luedemann M; Stadler D; Cheng CC; Protzer U; Knolle PA; Donakonda S
Comput Struct Biotechnol J; 2022; 20():799-811. PubMed ID: 35126884
[TBL] [Abstract][Full Text] [Related]
18. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
19. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
20. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
Gao LQ; Xu J; Chen SD
Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
